The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
-
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
-
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
-
John E. Niederhuber became the thirteenth director of the National Cancer Institute
On Sept. 1, 2006, President Bush appointed John E. Niederhuber, M.D., to be the 13th director of the…
-
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
-
Biotechnology | Diagnostics | NIH | Oncology
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health,…
-
Biotechnology | Diagnostics | NIH | Oncology
Gene expression profiling can accurately diagnose Burkitt’s lymphoma
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
-
Biotechnology | Disease | NIH | Oncology | Therapeutics | Women's Health
Osteoporosis drug shown to be as effective as Tamoxifen in preventing invasive breast cancer
On Apr. 17, 2006, the National Cancer Institute (NCI) announced initial results of the Study of Tamoxifen and…
-
Siteman Cancer Center was selected to be part of the National Comprehensive Cancer Network
On Mar. 22, 2006, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St….
-
Sanofi Pasteur delivered H5N1 vaccine for U.S. government pandemic initiatives
On Feb. 6, 2006, Sanofi pasteur announced it had delivered more H5N1 vaccine to the U.S. government including…
-
Biotechnology | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Dan L. Duncan contributed $100 million to the Baylor Cancer Center
On Jan. 31, 2006, Dan Duncan, founder of Enterprise Partners, an energy company in Houston, announced a donation…
-
The Winship Cancer Institute received a $7.9 million, 5-year grant from the NCI to study cell signaling in lung cancer
In 2006, the Winship Cancer Institute received a $7.9 million P01 5-year grant from the Cancer Institute (NCI)…
-
Robert C. Byrd Biotechnology Science Center opened
In 2006, Robert C. Byrd Biotechnology Science Center officially opened. The center was constructed with a grant of…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The 2-Year Extension of Postage Stamp for Breast Cancer Research (PL 109-100) was extended
On Nov. 11, 2005, the U.S. Congress authorized the 2-year extension of Postage Stamp for Breast Cancer Research…
-
National Cancer Institute launched a cancer biorepository pilot project to standardize biospecimen collection
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
-
The National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer initiative
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
-
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
-
Biotechnology | Disease | NIH | Oncology | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
-
The National Cancer Institute announced the Community Networks Program
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Women's Health
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
-
Biotechnology | Genomics | NIH | Oncology | Therapeutics
The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute (NCI) announced the creation of the cancer Biomedical Informatics Grid…
-
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
-
Diagnostics | Disease | NIH | Oncology
The Patient Navigator Research Program assessed impact of patient navigators
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
-
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
-
National Institutes of Health opened the Mark O Hatfield Clinical Research Center
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
-
Biotechnology | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
PNNL lands $10.3 million NIH biodefense contract to unlock proteomes of salmonella and pox
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
-
The National Cancer Institute announced the Alliance for Nanotechnology in Cancer
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
-
Biology | Diagnostics | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health
National Cancer Institute’s Annual Report to the Nation found cancer incidence and death rates on the decline
On Jun. 3, 2004, the National Cancer Institute’s (NCI) Annual Report to the Nation found cancer incidence and…
-
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
-
Biotechnology | NIH | Vaccine
NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…
